IDEX Biometrics ASA - Fully Underwritten Private Placement successfully placed - 21 July 2025

Core Viewpoint - IDEX Biometrics ASA has successfully completed a private placement, raising NOK 30 million through the issuance of new shares to support its commercialization efforts and general corporate purposes [3][11]. Group 1: Private Placement Details - The private placement involved the issuance of 9,090,909 Offer Shares at a subscription price of NOK 3.30 per share [3]. - The private placement is divided into two tranches: Tranche 1 consists of 4,731,594 Offer Shares, while Tranche 2 will include the remaining shares necessary to reach the total gross proceeds of NOK 30 million [5]. - The completion of Tranche 1 is expected to occur on or about 24 July 2025, while Tranche 2 is anticipated to settle on or about 18 August 2025 [10]. Group 2: Underwriters and Fees - Underwriters, including Altea AS and K-Konsult AS, have agreed to be allocated Offer Shares not applied for during the application period, with a total underwriting commitment of up to NOK 30 million [4]. - An underwriting fee of 5% will be paid to each underwriter in the form of 454,542 new shares, subject to approval by the extraordinary general meeting [4]. Group 3: Share Capital Changes - Following the completion of Tranche 1, the company's share capital will increase to NOK 52,095,850, divided into 52,095,850 shares [7]. - After the completion of both tranches and the issuance of underwriting shares, the total share capital will rise to NOK 56,909,707, divided into 56,909,707 shares [8]. Group 4: Compliance and Market Conditions - The Board has confirmed that the private placement complies with the equal treatment obligations under the Norwegian Securities Trading Act and Oslo Børs regulations [11]. - The decision to conduct a private placement is based on current market conditions and growth opportunities, allowing the company to raise capital efficiently [11][12].